학술논문
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
Document Type
Article
Author
Nutman, A.; Lellouche, J.; Temkin, E.; Carmeli, Y.; Yahav, D.; Daitch, V.; Leibovici, L.; Daikos, G.; Skiada, A.; Durante-Mangoni, E.; Bernardo, M.; Iossa, D.; Dishon-Benattar, Y.; Bitterman, R.; Paul, M.; Zusman, O.; Friberg, L.E.; Mouton, J.W.; Theuretzbacher, U.; Dickstein, Y.; Zayyad, H.; Koppel, F.; Zak-Doron, Y.; Altunin, S.; Andria, N.; Neuberger, A.; Stern, A.; Petersiel, N.; Raines, M.; Karban, A.; Eliakim-Raz, N.; Elbaz, M.; Atamna, H.; Babich, T.; Adler, A.; Levi, I.; Daikos, G.L.; Pavleas, I.; Antoniadou, A.; Kotsaki, A.; Andini, R.; Cavezza, G.; Bertolino, L.; Giuffre, G.; Giurazza, R.; Cuccurullo, S.; Galdo, M.; Murino, P.; Cristinziano, A.; Corcione, A.; Zampino, R.; Pafundi, P.C.; Mouton, J.; Friberg, L.; Kristoffersson, A.
Source
In: Clinical Microbiology and Infection . (Clinical Microbiology and Infection, September 2020, 26(9):1185-1191)
Subject
Language
English
ISSN
14690691
1198743X
1198743X